Hearing the words, “You have colon cancer,” is frightening. Typical day-to-day activities move to the side—as medical jargon, treatment options, doctor’s visits and test results take center stage.

If detected early, colon cancer can be cured 90% of the time. When found later, the battle is significantly more challenging and the prognosis is less encouraging.

Nearly 145,000 people are diagnosed with colorectal cancer every year. This year, it will take the lives of 51,000 people.

Leading-edge research 

Mezin-Koats Colon Cancer Research is proud to partner with the University of Minnesota Foundation to exclusively support research that advances the treatment and improves the quality of life for people battling colon cancer. 100% of your tax deductible donation will support colon cancer research through the Masonic Cancer Center at the University of Minnesota.

Innovative treatments

Among an elite group of 41 Comprehensive Care Centers nationwide, the Masonic Cancer Center at the University of Minnesota conducts leading-edge research and offers the most innovative investigatory treatments, translating laboratory research into targeted therapies for individual patients and applying relevant findings to larger populations.

Mission

The mission of Mezin-Koats Colon Cancer Research at the Masonic Cancer Center, University of Minnesota, is to advance the knowledge around the treatment of colon cancer with the hope of improving the quality of life and outcomes for people battling this disease.